SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-285164
Filing Date
2023-11-29
Accepted
2023-11-29 16:01:02
Documents
12
Period of Report
2023-11-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d49588d8k.htm   iXBRL 8-K 21345
  Complete submission text file 0001193125-23-285164.txt   150204

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA krro-20231127.xsd EX-101.SCH 2851
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE krro-20231127_lab.xml EX-101.LAB 19501
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE krro-20231127_pre.xml EX-101.PRE 12157
6 EXTRACTED XBRL INSTANCE DOCUMENT d49588d8k_htm.xml XML 3643
Mailing Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE. BUILDING 600-700 SUITE 6-401 CAMBRIDGE MA 02139 617-468-1900
Korro Bio, Inc. (Filer) CIK: 0001703647 (see all company filings)

IRS No.: 472324450 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39062 | Film No.: 231452099
SIC: 2834 Pharmaceutical Preparations